Gara Jalqabaatti › Saree (Gosoota Hunda) › North Carolina › Durham
Qorannoo klinikaalii Saree (Gosoota Hunda) Durham, NC keessatti
Qorannoo 58 Saree (Gosoota Hunda) f Durham fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
Namoota walitti qabaa jiraSadarkaa 1/2
- GSK Investigational Site, Durham
A Study of PHN-012 in Patients With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- PHN-012-001 Site, Durham
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Namoota walitti qabaa jiraQorannoo ilaalaa
- The University of North Carolina Chapel Hill, Chapel Hill · Miili 10 fagaatti
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Namoota walitti qabaa jiraSadarkaa 2/3
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · Miili 10 fagaatti
- University of North Carolina Hospitals at Hillsborough, Hillsborough · Miili 13 fagaatti
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Namoota walitti qabaa jiraSadarkaa 3
- Duke University Medical Center, Durham
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Duke University Medical Center - Duke Cancer Centre, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · Miili 10 fagaatti
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Namoota walitti qabaa jiraSadarkaa 3
- Quetzal Site 27, Chapel Hill · Miili 10 fagaatti
Study of the Effect of Innate on the Inflammatory Response to Endotoxin
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · Miili 7 fagaatti
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Namoota walitti qabaa jiraSadarkaa 2/3
- Duke University Medical Center, Durham
- The University of North Carolina at Chapel Hill, Chapel Hill · Miili 10 fagaatti
Digital Art Therapy for Young Cancer Survivors
Namoota walitti qabaa jira
- Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC
Namoota walitti qabaa jiraSadarkaa 1
- Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, Chapel Hill · Miili 10 fagaatti
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Namoota walitti qabaa jiraSadarkaa 2
- University of North Carolina at Chapel Hill, Chapel Hill · Miili 10 fagaatti
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Namoota walitti qabaa jiraSadarkaa 1/2
- University of North Carolina at Chapel Hill /ID# 272454, Chapel Hill · Miili 10 fagaatti
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Namoota walitti qabaa jiraSadarkaa 1
- Duke Cancer Institute, Durham
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Duke Cancer Institute, Durham
- University of North Carolina Medical Center, Chapel Hill · Miili 10 fagaatti
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Namoota walitti qabaa jiraSadarkaa 3
- Duke Cancer Center, Durham
Project: Every Child for Younger Patients With Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors
Namoota walitti qabaa jira
- University of North Carolina at Chapel Hill, Chapel Hill · Miili 10 fagaatti
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Namoota walitti qabaa jiraSadarkaa 3
- University of North Carolina Chapel Hill, Chapel Hill · Miili 10 fagaatti
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Duke University, Durham
Behavioral Pain Intervention for Older Cancer Patients
Namoota walitti qabaa jira
- Duke Cancer Network, Durham
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Duke Cancer Institute, Durham
Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Namoota walitti qabaa jiraSadarkaa 1/2
- University of North Carolina at Chapel Hill /ID# 274667, Chapel Hill · Miili 10 fagaatti
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 1
- University of North Carolina /ID# 251203, Chapel Hill · Miili 10 fagaatti
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Namoota walitti qabaa jiraSadarkaa 2
- Duke University Medical Center /ID# 279457, Durham
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Namoota walitti qabaa jiraSadarkaa 1
- Duke Cancer Center, Durham
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
Namoota walitti qabaa jira
- University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill · Miili 10 fagaatti
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Namoota walitti qabaa jira
- Durham VA Medical Center, Durham, NC, Durham
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of North Carolina, Chapel Hill · Miili 10 fagaatti
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Namoota walitti qabaa jiraSadarkaa 1
- Research Site, Durham
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Duke Cancer Center /ID# 251975, Durham
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 2
- Duke Comprehensive Cancer Center, Durham
- University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
Preserving Physical Function in Older Adults With Cancer: Impact of an Optimizing Nutrition Intervention Applied Before and After Surgery
Namoota walitti qabaa jira
- Durham VA Medical Center, Durham, NC, Durham
Improving Outcomes in Early Menopause After Cancer
Namoota walitti qabaa jira
- Duke Cancer Institute, Durham
UNC Childhood, Adolescent, and Young Adult Cancer Cohort
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of North Carolina at Chapel Hill, Chapel Hill · Miili 10 fagaatti
Pilot Study of Mindset Moments Among Adolescent and Young Adult Cancer Survivors
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- Duke Cancer Institute, Durham
UNC Metastatic Cancer Radiation Therapy Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · Miili 10 fagaatti
Local Radiofrequency Ablation Plus External Beam Radiation for the Treatment of Painful Thoracic and Lumbar Spine Tumors
Namoota walitti qabaa jiraQorannoo ilaalaa
- UNC Hospitals, Chapel Hill · Miili 10 fagaatti
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Namoota walitti qabaa jiraSadarkaa 1/2
- Duke University Medical Center, Duke Cancer Center, Durham
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Namoota walitti qabaa jira
- Durham VA Medical Center, Durham, NC, Durham
Rehabilitation Outcomes Study
Namoota walitti qabaa jira
- The N.C. Cancer Hospital, Chapel Hill · Miili 10 fagaatti
Cancer and Mild Cognitive Impairment Dyadic Intervention
Namoota walitti qabaa jira
- Duke University, Durham
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Namoota walitti qabaa jiraSadarkaa 2
- University of North Carolina /ID# 233313, Chapel Hill · Miili 10 fagaatti
GEMINI-NSCLC: NSCLC Biomarker Study
Namoota walitti qabaa jiraQorannoo ilaalaa
- Duke University, Durham
- UNC, Chapel Hill · Miili 10 fagaatti
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
Namoota walitti qabaa jira
- Duke Cancer Institute, Durham
Effectiveness of Central Oncology Navigation and the Use of an ORN
Namoota walitti qabaa jira
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
Cognitive Behavioral Theory-assisted Virtual Reality for Chronic CANcer Pain (VR-CAN)
Namoota walitti qabaa jira
- Duke University School of Medicine, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Chapel Hill · Miili 10 fagaatti
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · Miili 10 fagaatti
Young Adult Infusion Space Experience Satisfaction Survey
Namoota walitti qabaa jiraQorannoo ilaalaa
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
UNC Pleural Fluid Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- UNC Lingeberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
A Study of NX-1607 in Adults With Advanced Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- University of North Carolina, Chapel Hill · Miili 10 fagaatti
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Namoota walitti qabaa jira
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · Miili 10 fagaatti
- University of North Carolina Hospitals - Hillsborough Campus, Hillsborough · Miili 13 fagaatti
Qorannoo Saree (Gosoota Hunda) magaalota biroo keessatti
- Houston, TXQorannoo 121
- New York City, NYQorannoo 109
- Boston, MAQorannoo 85
- Los Angeles, CAQorannoo 74
- Nashville, TNQorannoo 65
- Philadelphia, PAQorannoo 59
- Washington, DCQorannoo 58
- Chicago, ILQorannoo 51
- Atlanta, GAQorannoo 49
- Seattle, WAQorannoo 49
- Arlington, VAQorannoo 48
- St. Louis, MOQorannoo 46
Qorannoo biroo Durham keessatti
- Saree OljooQorannoo 64
- Kansara Qara'a Non-Small CellQorannoo 39
- Myeloma Baay’eeQorannoo 37
- Leukemia Myeloidii HamaaQorannoo 33
- Kansara MetastatikiiQorannoo 33
- Kansarii ProstateQorannoo 32
- Dhibee QaraQorannoo 32
- Kansarii ColorectalQorannoo 28
- Kansarii OvariiQorannoo 27
- Luukemiya Limfoositiikii KeessummaaQorannoo 27
- Cufama OnneeQorannoo 26
- Kansarii PancreasQorannoo 24
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.